Molecular Imaging Assessment of ACL Viability

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 9, 2013

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

ACL Injury

Interventions

DEVICE

PET scan

low dose fluorodeoxyglucose (FDG) PET research scan with CEST sequence

DEVICE

MRI scan

standard of care MRI

Trial Locations (1)

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors

lead

University of Cincinnati

OTHER

NCT03491046 - Molecular Imaging Assessment of ACL Viability | Biotech Hunter | Biotech Hunter